NCBI Taxonomy: 298378

3,9,15-Tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone

C45H57N3O9 (783.4095)

[Raw Data] CBA19_Beauvericin_pos_20eV_1-1_01_1374.txt [Raw Data] CBA19_Beauvericin_pos_50eV_1-1_01_1485.txt [Raw Data] CBA19_Beauvericin_pos_10eV_1-1_01_1352.txt [Raw Data] CBA19_Beauvericin_pos_40eV_1-1_01_1376.txt [Raw Data] CBA19_Beauvericin_pos_30eV_1-1_01_1483.txt Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1]. Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1].

Fusarine

C14H15NO3 (245.1052)

Beauvericin

C45H57N3O9 (783.4095)

A trimeric cyclodepsipeptide composed from alternating methylphenylalanyl and hydroxyvaleryl residues. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2334 CONFIDENCE Reference Standard (Level 1) Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1]. Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1].

4-hydroxy-3-(1-{[2-(4-hydroxyphenyl)ethyl]imino}ethyl)-6-methylpyran-2-one

C16H17NO4 (287.1158)

3-ethanimidoyl-4-hydroxy-6-methylpyran-2-one

C8H9NO3 (167.0582)

(3z)-3-(1-{[2-(4-hydroxyphenyl)ethyl]amino}ethylidene)-6-methylpyran-2,4-dione

C16H17NO4 (287.1158)

(3z)-3-(1-aminoethylidene)-6-methylpyran-2,4-dione

C8H9NO3 (167.0582)

(3ar,8ar)-1h,2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl acetate

C12H14N2O2 (218.1055)

beauvericin

C45H57N3O9 (783.4095)

{"Ingredient_id": "HBIN017671","Ingredient_name": "beauvericin","Alias": "NA","Ingredient_formula": "C45H57N3O9","Ingredient_Smile": "CC(C)C1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC2=CC=CC=C2)C)C(C)C)CC3=CC=CC=C3)C)C(C)C)CC4=CC=CC=C4)C","Ingredient_weight": "783.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2188","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44419427","DrugBank_id": "NA"}

3-[(2r,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4e,6e,9z)-3-hydroxy-2,6,8,10,12-pentamethyloctadeca-4,6,9-trien-2-yl]pyran-2-one

C34H54O8 (590.3818)

1h,2h,3h,4h-furo[2,3-g]indol-3a-ol

C10H11NO2 (177.079)

3-[(2r,3r,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(3s,4e,6e,8s)-8-[(1z,4r)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-2-hydroxypyran-4-one

C34H54O9 (606.3768)

2h,3h,8h,8ah-furo[2,3-b]indol-3a-ol

C10H11NO2 (177.079)

3-[(2s,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

n-{4-[2-formyl-5-(hydroxymethyl)pyrrol-1-yl]butyl}ethanimidic acid

C12H18N2O3 (238.1317)

3-[(2s,3r,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-hydroxy-6-[(3s,4e,6e,8r,9z,12r)-3-hydroxy-2,6,8,10,12-pentamethyloctadeca-4,6,9-trien-2-yl]pyran-4-one

C34H54O8 (590.3818)

1h,2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl acetate

C12H14N2O2 (218.1055)

3-[(2r,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

(2'r,4's,10'r,11's)-11'-(acetyloxy)-2'-[(acetyloxy)methyl]-10'-hydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-4'-yl 3-methylbutanoate

C24H34O9 (466.2203)

n-{5-[2-formyl-5-(hydroxymethyl)pyrrol-1-yl]pentyl}ethanimidic acid

C13H20N2O3 (252.1474)

(3s,6s,9s,15ar)-1,4,7-trihydroxy-6-[(1-methoxyindol-3-yl)methyl]-3-(6-oxooctyl)-9-(sec-butyl)-3h,6h,9h,12h,13h,14h,15h,15ah-pyrido[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C34H49N5O6 (623.3683)

3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-(3-hydroxy-2,6,8,10,12-pentamethyloctadeca-4,6,9-trien-2-yl)pyran-2-one

C34H54O8 (590.3818)

3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[8-(2,4-dimethyldec-1-en-1-yl)-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

2-methyl-n-(2-methylpropyl)but-2-enimidic acid

C9H17NO (155.131)

1-{1h,3h,4h,9h-pyrido[3,4-b]indol-2-yl}ethanone

C13H14N2O (214.1106)

(3ar,8as)-2h,3h,8h,8ah-furo[2,3-b]indol-3a-ol

C10H11NO2 (177.079)

3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4e,6e,9e)-3-hydroxy-2,6,8,10,12-pentamethyloctadeca-4,6,9-trien-2-yl]pyran-2-one

C34H54O8 (590.3818)

(1's,2r,2'r,4's,7'r,10'r)-11'-(acetyloxy)-2'-[(acetyloxy)methyl]-10'-hydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-4'-yl 3-methylbutanoate

C24H34O9 (466.2203)

(3r,6s,9r,12s,15r,18s)-3,9,15-tribenzyl-6,12,18-triisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone

C45H57N3O9 (783.4095)

(2e)-2-methyl-n-(2-methylpropyl)but-2-enimidic acid

C9H17NO (155.131)